|
|
| | NSC 354646 Basic information |
| Product Name: | NSC 354646 | | Synonyms: | NSC 354646;(8S,10S)-7,8,9,10-Tetrahydro-6,8α,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10α-[[2,3,6-trideoxy-3-(4-morpholinyl)-α-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione;3'-Deamino-3'-(4-morpholinyl)adriamycin;3'-Deamino-3'-(4-morpholinyl)doxorubicin;Morpholinodoxorubicin;3'-Deamino-3'-(4-morpholinyl)daunorubicin;3'-Deamino-3'-morpholino-adriamycin;3'-Morpholino-3'-deaminodaunorubicin | | CAS: | 80790-68-7 | | MF: | C31H35NO12 | | MW: | 613.6091 | | EINECS: | | | Product Categories: | | | Mol File: | 80790-68-7.mol |  |
| | NSC 354646 Chemical Properties |
| Melting point | 154-160 °C | | Boiling point | 659.48°C (rough estimate) | | density | 1.3069 (rough estimate) | | refractive index | 1.6310 (estimate) | | pka | 7.35±0.60(Predicted) |
| | NSC 354646 Usage And Synthesis |
| | NSC 354646 Preparation Products And Raw materials |
|